140 related articles for article (PubMed ID: 37239533)
1. A Review of the Role of Pollen in COVID-19 Infection.
Idrose NS; Zhang J; Lodge CJ; Erbas B; Douglass JA; Bui DS; Dharmage SC
Int J Environ Res Public Health; 2023 May; 20(10):. PubMed ID: 37239533
[TBL] [Abstract][Full Text] [Related]
2. Does airborne pollen influence COVID-19 outbreak?
Ravindra K; Goyal A; Mor S
Sustain Cities Soc; 2021 Jul; 70():102887. PubMed ID: 33816082
[TBL] [Abstract][Full Text] [Related]
3. Ivermectin for preventing and treating COVID-19.
Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
[TBL] [Abstract][Full Text] [Related]
4. Higher airborne pollen concentrations correlated with increased SARS-CoV-2 infection rates, as evidenced from 31 countries across the globe.
Damialis A; Gilles S; Sofiev M; Sofieva V; Kolek F; Bayr D; Plaza MP; Leier-Wirtz V; Kaschuba S; Ziska LH; Bielory L; Makra L; Del Mar Trigo M; ; Traidl-Hoffmann C
Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33798095
[TBL] [Abstract][Full Text] [Related]
5. Physical interventions to interrupt or reduce the spread of respiratory viruses.
Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
[TBL] [Abstract][Full Text] [Related]
6. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
7. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
8. Community Outbreak Investigation of SARS-CoV-2 Transmission Among Bus Riders in Eastern China.
Shen Y; Li C; Dong H; Wang Z; Martinez L; Sun Z; Handel A; Chen Z; Chen E; Ebell MH; Wang F; Yi B; Wang H; Wang X; Wang A; Chen B; Qi Y; Liang L; Li Y; Ling F; Chen J; Xu G
JAMA Intern Med; 2020 Dec; 180(12):1665-1671. PubMed ID: 32870239
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
Kreuzberger N; Hirsch C; Chai KL; Tomlinson E; Khosravi Z; Popp M; Neidhardt M; Piechotta V; Salomon S; Valk SJ; Monsef I; Schmaderer C; Wood EM; So-Osman C; Roberts DJ; McQuilten Z; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013825. PubMed ID: 34473343
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 infection as a trigger of autoimmune response.
Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R
Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235
[TBL] [Abstract][Full Text] [Related]
11. The Relation of the Viral Structure of SARS-CoV-2, High-Risk Condition, and Plasma Levels of IL-4, IL-10, and IL-15 in COVID-19 Patients Compared to SARS and MERS Infections.
Mousavizadeh L; Soltani R; Abedini K; Ghasemi S
Curr Mol Med; 2022; 22(7):584-593. PubMed ID: 34607539
[TBL] [Abstract][Full Text] [Related]
12. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
13. Variants in ACE2; potential influences on virus infection and COVID-19 severity.
Bakhshandeh B; Sorboni SG; Javanmard AR; Mottaghi SS; Mehrabi MR; Sorouri F; Abbasi A; Jahanafrooz Z
Infect Genet Evol; 2021 Jun; 90():104773. PubMed ID: 33607284
[TBL] [Abstract][Full Text] [Related]
14. Asthma and COVID-19: an update.
Adir Y; Saliba W; Beurnier A; Humbert M
Eur Respir Rev; 2021 Dec; 30(162):. PubMed ID: 34911694
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 infection in the first trimester and the risk of early miscarriage: a UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemic.
Balachandren N; Davies MC; Hall JA; Stephenson JM; David AL; Barrett G; O'Neill HC; Ploubidis GB; Yasmin E; Mavrelos D
Hum Reprod; 2022 May; 37(6):1126-1133. PubMed ID: 35389480
[TBL] [Abstract][Full Text] [Related]
16. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
18. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).
Shanmugaraj B; Siriwattananon K; Wangkanont K; Phoolcharoen W
Asian Pac J Allergy Immunol; 2020 Mar; 38(1):10-18. PubMed ID: 32134278
[TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
20. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.
Bchetnia M; Girard C; Duchaine C; Laprise C
J Infect Public Health; 2020 Nov; 13(11):1601-1610. PubMed ID: 32778421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
